| negative regulation of establishment of protein localization to plasma membrane | GO:0090005 | 9 | 0.925 | Human |
| axon cargo transport | GO:0008088 | 2 | 0.902 | |
| regulation of axon guidance | GO:1902667 | 3 | 0.878 | |
| regulation of axon extension involved in axon guidance | GO:0048841 | 2 | 0.810 | |
| regulation of protein localization to plasma membrane | GO:1903076 | 40 | 0.658 | Human |
| microtubule based process | GO:0007017 | 210 | 0.627 | |
| neuromuscular junction development | GO:0007528 | 3 | 0.584 | Fly |
| membrane organization | GO:0061024 | 292 | 0.564 | Human |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.534 | Human |
| retinal ganglion cell axon guidance | GO:0031290 | 2 | 0.527 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.493 | |
| protein localization to plasma membrane | GO:0072659 | 93 | 0.470 | Human |
| regulation of behavior | GO:0050795 | 82 | 0.419 | |
| establishment of protein localization to membrane | GO:0090150 | 121 | 0.389 | Human |
| microtubule based movement | GO:0007018 | 32 | 0.375 | |
| actin filament organization | GO:0007015 | 128 | 0.336 | |
| regulation of response to external stimulus | GO:0032101 | 222 | 0.326 | |
| post embryonic development | GO:0009791 | 2 | 0.323 | Worm |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.322 | Human |
| negative regulation of organelle organization | GO:0010639 | 126 | 0.311 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.290 | Human |
| protein localization to membrane | GO:0072657 | 160 | 0.266 | Human |
| plasma membrane organization | GO:0007009 | 115 | 0.261 | Human |
| mitotic cell cycle | GO:0000278 | 326 | 0.259 | Human |
| regulation of chemotaxis | GO:0050920 | 74 | 0.246 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 156 | 0.231 | Human |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.221 | Human |
| regulation of protein localization | GO:0032880 | 296 | 0.218 | Human |
| chemical homeostasis | GO:0048878 | 306 | 0.216 | Fly |
| endomembrane system organization | GO:0010256 | 196 | 0.215 | Human |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.194 | Human |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.183 | |
| single organism cellular localization | GO:1902580 | 332 | 0.179 | Human |
| regulation of meiotic cell cycle | GO:0051445 | 4 | 0.179 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.174 | Human |
| regulation of meiosis | GO:0040020 | 3 | 0.168 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.164 | Human |
| apoptotic process involved in morphogenesis | GO:0060561 | 3 | 0.164 | |
| meiotic chromosome segregation | GO:0045132 | 4 | 0.163 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 116 | 0.161 | |
| cell cell signaling | GO:0007267 | 155 | 0.155 | Fly |
| cytoskeleton dependent intracellular transport | GO:0030705 | 21 | 0.146 | |
| regulation of neurogenesis | GO:0050767 | 82 | 0.145 | |
| negative regulation of stress fiber assembly | GO:0051497 | 8 | 0.140 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 244 | 0.135 | Human |
| regulation of cellular component movement | GO:0051270 | 334 | 0.134 | |
| synaptic transmission | GO:0007268 | 61 | 0.133 | Fly |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 83 | 0.132 | |
| nervous system development | GO:0007399 | 293 | 0.131 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.129 | |
| single organism membrane organization | GO:0044802 | 268 | 0.128 | Human |
| negative regulation of protein localization to plasma membrane | GO:1903077 | 13 | 0.126 | Human |
| mitotic cell cycle phase transition | GO:0044772 | 162 | 0.125 | Human |
| positive regulation of cell death | GO:0010942 | 263 | 0.125 | |
| regulation of actin filament based process | GO:0032970 | 141 | 0.125 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.124 | Human |
| ras protein signal transduction | GO:0007265 | 73 | 0.123 | |
| cell cycle checkpoint | GO:0000075 | 117 | 0.123 | Human |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.121 | |
| organelle localization | GO:0051640 | 84 | 0.117 | Fly |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.117 | |
| dephosphorylation | GO:0016311 | 209 | 0.113 | Human |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.113 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.113 | |
| vesicle localization | GO:0051648 | 26 | 0.110 | Fly |
| microtubule organizing center organization | GO:0031023 | 62 | 0.109 | |
| locomotory behavior | GO:0007626 | 1 | 0.107 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.107 | Human |
| negative regulation of cytoskeleton organization | GO:0051494 | 45 | 0.106 | |
| regulation of cell projection organization | GO:0031344 | 107 | 0.105 | |
| regulation of kinase activity | GO:0043549 | 314 | 0.100 | Human |
| axon extension involved in axon guidance | GO:0048846 | 5 | 0.099 | |
| regulation of sister chromatid segregation | GO:0033045 | 27 | 0.098 | |
| microtubule based transport | GO:0010970 | 21 | 0.096 | |
| cell development | GO:0048468 | 328 | 0.094 | |
| proteasomal protein catabolic process | GO:0010498 | 176 | 0.093 | Human |
| small gtpase mediated signal transduction | GO:0007264 | 78 | 0.092 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.091 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.091 | Human |
| regulation of actin filament bundle assembly | GO:0032231 | 36 | 0.090 | |
| cell projection organization | GO:0030030 | 252 | 0.089 | |
| negative regulation of actin filament bundle assembly | GO:0032232 | 9 | 0.088 | |
| positive regulation of hydrolase activity | GO:0051345 | 331 | 0.088 | |
| actin filament based process | GO:0030029 | 224 | 0.086 | |
| regulation of transferase activity | GO:0051338 | 355 | 0.086 | Human |
| positive regulation of cell cycle process | GO:0090068 | 106 | 0.086 | Human |
| vesicle mediated transport | GO:0016192 | 371 | 0.085 | |
| oogenesis | GO:0048477 | 2 | 0.085 | |
| regulation of growth | GO:0040008 | 165 | 0.085 | |
| lipid metabolic process | GO:0006629 | 381 | 0.082 | Human |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.082 | |
| protein catabolic process | GO:0030163 | 325 | 0.079 | Human |
| cellular protein catabolic process | GO:0044257 | 261 | 0.079 | Human |
| cell cycle arrest | GO:0007050 | 71 | 0.078 | Human |
| protein dephosphorylation | GO:0006470 | 81 | 0.077 | Human |
| regulation of locomotion | GO:0040012 | 329 | 0.076 | |
| regulation of cell growth | GO:0001558 | 135 | 0.075 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 267 | 0.074 | Human |
| regulation of cell division | GO:0051302 | 116 | 0.074 | |
| negative regulation of lipid metabolic process | GO:0045833 | 38 | 0.072 | Human |
| spindle assembly | GO:0051225 | 29 | 0.070 | |
| regulation of anatomical structure size | GO:0090066 | 101 | 0.068 | |
| regulation of cell cycle phase transition | GO:1901987 | 126 | 0.068 | Human |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.068 | Human |
| chemotaxis | GO:0006935 | 157 | 0.066 | |
| signal transduction in absence of ligand | GO:0038034 | 22 | 0.066 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 4 | 0.066 | |
| negative regulation of cell cycle process | GO:0010948 | 121 | 0.065 | Human |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.065 | |
| growth | GO:0040007 | 202 | 0.064 | |
| regeneration | GO:0031099 | 4 | 0.064 | |
| nuclear division | GO:0000280 | 128 | 0.063 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 119 | 0.063 | |
| lipid biosynthetic process | GO:0008610 | 177 | 0.062 | |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.062 | Human |
| negative regulation of protein processing | GO:0010955 | 142 | 0.061 | |
| regulation of nervous system development | GO:0051960 | 88 | 0.061 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 118 | 0.060 | Human |
| reproduction | GO:0000003 | 63 | 0.059 | |
| positive regulation of cell division | GO:0051781 | 59 | 0.058 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.058 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.058 | |
| regulation of axonogenesis | GO:0050770 | 16 | 0.057 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.056 | Human |
| dna integrity checkpoint | GO:0031570 | 71 | 0.056 | Human |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.055 | Human |
| regulation of cell cycle arrest | GO:0071156 | 36 | 0.055 | Human |
| regulation of neuron projection development | GO:0010975 | 57 | 0.054 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.054 | |
| developmental programmed cell death | GO:0010623 | 3 | 0.054 | |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 44 | 0.054 | Human |
| organelle assembly | GO:0070925 | 176 | 0.053 | |
| generation of neurons | GO:0048699 | 152 | 0.053 | |
| dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest | GO:0006977 | 9 | 0.052 | Human |
| eye photoreceptor cell differentiation | GO:0001754 | 2 | 0.052 | |
| neuronal stem cell division | GO:0036445 | 1 | 0.050 | |
| regulation of cell migration | GO:0030334 | 289 | 0.050 | |
| phospholipid metabolic process | GO:0006644 | 99 | 0.049 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 85 | 0.049 | |
| regulation of establishment of protein localization to plasma membrane | GO:0090003 | 30 | 0.048 | Human |
| gtp catabolic process | GO:0006184 | 237 | 0.048 | |
| cellular homeostasis | GO:0019725 | 196 | 0.048 | |
| chromosome segregation | GO:0007059 | 114 | 0.047 | |
| positive regulation of meiotic cell cycle | GO:0051446 | 2 | 0.047 | |
| cell division | GO:0051301 | 168 | 0.047 | |
| negative regulation of apoptotic process | GO:0043066 | 316 | 0.047 | |
| mitotic cell cycle checkpoint | GO:0007093 | 68 | 0.046 | Human |
| axon regeneration | GO:0031103 | 1 | 0.046 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 89 | 0.046 | Human |
| positive regulation of protein phosphorylation | GO:0001934 | 313 | 0.045 | |
| regulation of cytoskeleton organization | GO:0051493 | 177 | 0.044 | |
| mitochondrion organization | GO:0007005 | 156 | 0.044 | |
| positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001241 | 4 | 0.044 | |
| stem cell division | GO:0017145 | 2 | 0.044 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.043 | |
| regulation of cellular component size | GO:0032535 | 82 | 0.043 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.042 | |
| cellular chemical homeostasis | GO:0055082 | 180 | 0.042 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 85 | 0.042 | Human |
| spindle organization | GO:0007051 | 53 | 0.042 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.042 | |
| neuroblast proliferation | GO:0007405 | 4 | 0.042 | |
| regulation of lipid metabolic process | GO:0019216 | 96 | 0.040 | Human |
| behavior | GO:0007610 | 112 | 0.040 | |
| centrosome organization | GO:0051297 | 58 | 0.040 | |
| blood vessel development | GO:0001568 | 172 | 0.039 | |
| regulation of cell development | GO:0060284 | 161 | 0.039 | |
| taxis | GO:0042330 | 157 | 0.039 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.039 | |
| phosphatidic acid biosynthetic process | GO:0006654 | 4 | 0.038 | |
| negative regulation of kinase activity | GO:0033673 | 106 | 0.038 | Human |
| canonical wnt signaling pathway | GO:0060070 | 116 | 0.038 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.038 | Human |
| signal transduction by p53 class mediator | GO:0072331 | 72 | 0.037 | Human |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.037 | |
| neuroblast division | GO:0055057 | 1 | 0.037 | |
| positive regulation of programmed cell death | GO:0043068 | 249 | 0.037 | |
| regulation of oocyte development | GO:0060281 | 1 | 0.037 | |
| actomyosin structure organization | GO:0031032 | 59 | 0.036 | |
| cell part morphogenesis | GO:0032990 | 137 | 0.035 | |
| mitotic spindle organization | GO:0007052 | 27 | 0.035 | |
| positive regulation of apoptotic process | GO:0043065 | 246 | 0.034 | |
| multicellular organismal reproductive process | GO:0048609 | 40 | 0.034 | |
| protein processing | GO:0016485 | 226 | 0.034 | Human |
| signal transduction in response to dna damage | GO:0042770 | 57 | 0.033 | Human |
| establishment of organelle localization | GO:0051656 | 59 | 0.033 | |
| organelle fission | GO:0048285 | 149 | 0.033 | |
| negative regulation of transferase activity | GO:0051348 | 124 | 0.033 | Human |
| negative regulation of cell proliferation | GO:0008285 | 228 | 0.032 | Human |
| negative regulation of protein maturation | GO:1903318 | 142 | 0.032 | |
| autophagy | GO:0006914 | 88 | 0.032 | Fly |
| regulation of neuron differentiation | GO:0045664 | 70 | 0.032 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.031 | |
| positive regulation of protein kinase activity | GO:0045860 | 190 | 0.031 | |
| negative regulation of mitotic sister chromatid separation | GO:2000816 | 17 | 0.031 | |
| circulatory system development | GO:0072359 | 262 | 0.031 | |
| asymmetric neuroblast division | GO:0055059 | 1 | 0.030 | |
| female gamete generation | GO:0007292 | 2 | 0.030 | |
| cell projection morphogenesis | GO:0048858 | 129 | 0.030 | |
| negative regulation of protein modification process | GO:0031400 | 200 | 0.030 | |
| response to wounding | GO:0009611 | 168 | 0.030 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.029 | |
| regulation of protein dephosphorylation | GO:0035304 | 18 | 0.029 | Human |
| neuron projection development | GO:0031175 | 106 | 0.029 | |
| synaptic vesicle localization | GO:0097479 | 5 | 0.029 | Fly |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 50 | 0.029 | Human |
| g1 dna damage checkpoint | GO:0044783 | 18 | 0.029 | Human |
| regulation of protein stability | GO:0031647 | 87 | 0.029 | |
| reproductive process | GO:0022414 | 106 | 0.028 | |
| positive regulation of cell cycle arrest | GO:0071158 | 23 | 0.028 | Human |
| reactive oxygen species metabolic process | GO:0072593 | 75 | 0.028 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.028 | |
| cell morphogenesis | GO:0000902 | 296 | 0.028 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.027 | |
| purine ribonucleotide catabolic process | GO:0009154 | 404 | 0.027 | |
| developmental growth involved in morphogenesis | GO:0060560 | 23 | 0.027 | |
| rna interference | GO:0016246 | 4 | 0.027 | |
| negative regulation of cell division | GO:0051782 | 31 | 0.027 | |
| regulation of neuroblast proliferation | GO:1902692 | 3 | 0.027 | |
| cell growth | GO:0016049 | 160 | 0.027 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 127 | 0.027 | |
| regulation of cell motility | GO:2000145 | 299 | 0.026 | |
| purine ribonucleoside metabolic process | GO:0046128 | 437 | 0.026 | |
| synaptic vesicle transport | GO:0048489 | 5 | 0.026 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.026 | |
| embryo development | GO:0009790 | 123 | 0.026 | Worm |
| multicellular organism reproduction | GO:0032504 | 42 | 0.026 | |
| regulation of small gtpase mediated signal transduction | GO:0051056 | 156 | 0.026 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.026 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 60 | 0.026 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.026 | |
| regulation of map kinase activity | GO:0043405 | 108 | 0.025 | |
| actin filament bundle organization | GO:0061572 | 54 | 0.025 | |
| neuron projection extension involved in neuron projection guidance | GO:1902284 | 5 | 0.025 | |
| regulation of stress fiber assembly | GO:0051492 | 32 | 0.025 | |
| segmentation | GO:0035282 | 4 | 0.025 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 41 | 0.025 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.025 | |
| somatic stem cell division | GO:0048103 | 1 | 0.025 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.025 | |
| establishment of vesicle localization | GO:0051650 | 23 | 0.024 | |
| regulation of nuclear division | GO:0051783 | 65 | 0.024 | |
| neurogenesis | GO:0022008 | 169 | 0.024 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.024 | |
| reproductive structure development | GO:0048608 | 55 | 0.024 | |
| multi organism reproductive process | GO:0044703 | 54 | 0.024 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.023 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.023 | Human |
| regulation of nucleotide catabolic process | GO:0030811 | 205 | 0.023 | |
| cell cycle phase transition | GO:0044770 | 173 | 0.023 | Human |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.023 | |
| protein maturation | GO:0051604 | 233 | 0.023 | Human |
| compound eye development | GO:0048749 | 1 | 0.023 | |
| protein stabilization | GO:0050821 | 64 | 0.023 | |
| intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator | GO:0042771 | 23 | 0.022 | Human |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.022 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.022 | |
| protein localization to nucleus | GO:0034504 | 136 | 0.022 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 179 | 0.022 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 102 | 0.022 | Human |
| spermatid differentiation | GO:0048515 | 4 | 0.022 | |
| asymmetric stem cell division | GO:0098722 | 1 | 0.022 | |
| somatic muscle development | GO:0007525 | 1 | 0.022 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 88 | 0.021 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.021 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 70 | 0.021 | |
| somitogenesis | GO:0001756 | 2 | 0.021 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 13 | 0.021 | Human |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 42 | 0.021 | Human |
| negative regulation of g1 s transition of mitotic cell cycle | GO:2000134 | 29 | 0.021 | Human |
| neuron differentiation | GO:0030182 | 138 | 0.021 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.021 | |
| guanosine containing compound catabolic process | GO:1901069 | 239 | 0.020 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.020 | |
| positive regulation of growth | GO:0045927 | 58 | 0.020 | |
| purine nucleotide catabolic process | GO:0006195 | 405 | 0.020 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.020 | |
| secretion by cell | GO:0032940 | 226 | 0.020 | |
| guanosine containing compound metabolic process | GO:1901068 | 244 | 0.020 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.020 | |
| cell morphogenesis involved in neuron differentiation | GO:0048667 | 44 | 0.020 | |
| internal peptidyl lysine acetylation | GO:0018393 | 97 | 0.020 | |
| male meiosis | GO:0007140 | 1 | 0.019 | |
| regulation of protein processing | GO:0070613 | 150 | 0.019 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.019 | |
| actin filament bundle assembly | GO:0051017 | 54 | 0.019 | |
| negative regulation of epithelial to mesenchymal transition | GO:0010719 | 14 | 0.019 | |
| multi multicellular organism process | GO:0044706 | 18 | 0.019 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 422 | 0.019 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.018 | |
| negative regulation of transport | GO:0051051 | 176 | 0.018 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 394 | 0.018 | |
| regulation of ion transport | GO:0043269 | 189 | 0.018 | |
| oxidation reduction process | GO:0055114 | 396 | 0.018 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 127 | 0.018 | Human |
| negative regulation of mitotic metaphase anaphase transition | GO:0045841 | 17 | 0.018 | |
| response to radiation | GO:0009314 | 151 | 0.018 | |
| positive regulation of kinase activity | GO:0033674 | 204 | 0.018 | |
| regulation of dephosphorylation | GO:0035303 | 96 | 0.017 | Human |
| response to hydrogen peroxide | GO:0042542 | 40 | 0.017 | |
| dna damage checkpoint | GO:0000077 | 68 | 0.017 | Human |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.017 | |
| peptidyl glutamic acid modification | GO:0018200 | 4 | 0.017 | |
| protein localization to organelle | GO:0033365 | 280 | 0.017 | |
| regulation of multi organism process | GO:0043900 | 157 | 0.017 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.017 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 2 | 0.017 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.017 | |
| endocytosis | GO:0006897 | 159 | 0.017 | |
| regulation of lipid kinase activity | GO:0043550 | 19 | 0.017 | Human |
| mitotic nuclear division | GO:0007067 | 119 | 0.017 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 116 | 0.017 | |
| cell fate determination | GO:0001709 | 3 | 0.017 | |
| nucleus organization | GO:0006997 | 28 | 0.017 | |
| developmental cell growth | GO:0048588 | 18 | 0.017 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.017 | Human |
| organ formation | GO:0048645 | 3 | 0.017 | |
| signal transduction by phosphorylation | GO:0023014 | 297 | 0.017 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.017 | |
| mitotic spindle checkpoint | GO:0071174 | 18 | 0.016 | |
| organic acid biosynthetic process | GO:0016053 | 97 | 0.016 | |
| cytokinesis | GO:0000910 | 96 | 0.016 | |
| cerebellum development | GO:0021549 | 2 | 0.016 | |
| spermatid development | GO:0007286 | 4 | 0.016 | |
| regulation of response to wounding | GO:1903034 | 101 | 0.016 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.016 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.016 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.016 | |
| establishment of protein localization to plasma membrane | GO:0090002 | 68 | 0.016 | Human |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.016 | |
| response to axon injury | GO:0048678 | 1 | 0.016 | |
| neuron projection morphogenesis | GO:0048812 | 50 | 0.016 | |
| regulation of protein catabolic process | GO:0042176 | 155 | 0.016 | |
| spindle checkpoint | GO:0031577 | 26 | 0.015 | |
| peripheral nervous system development | GO:0007422 | 2 | 0.015 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.015 | |
| axon extension | GO:0048675 | 13 | 0.015 | |
| response to biotic stimulus | GO:0009607 | 276 | 0.015 | |
| amine metabolic process | GO:0009308 | 44 | 0.015 | |
| ribonucleoside catabolic process | GO:0042454 | 406 | 0.015 | |
| blood vessel morphogenesis | GO:0048514 | 162 | 0.015 | |
| regulation of mitotic sister chromatid segregation | GO:0033047 | 27 | 0.015 | |
| thymus development | GO:0048538 | 3 | 0.015 | |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand | GO:2001239 | 20 | 0.015 | |
| oocyte development | GO:0048599 | 1 | 0.015 | |
| signal transduction involved in mitotic dna integrity checkpoint | GO:1902403 | 13 | 0.014 | Human |
| hindbrain development | GO:0030902 | 3 | 0.014 | |
| vasculature development | GO:0001944 | 181 | 0.014 | |
| stress fiber assembly | GO:0043149 | 40 | 0.014 | |
| cellular response to oxygen containing compound | GO:1901701 | 276 | 0.014 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.014 | |
| positive regulation of phosphorylation | GO:0042327 | 394 | 0.014 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 119 | 0.014 | |
| internal protein amino acid acetylation | GO:0006475 | 101 | 0.014 | |
| response to metal ion | GO:0010038 | 84 | 0.014 | |
| regulation of chromosome organization | GO:0033044 | 103 | 0.014 | |
| regulation of gtp catabolic process | GO:0033124 | 180 | 0.014 | |
| purine nucleoside catabolic process | GO:0006152 | 398 | 0.014 | |
| single organism carbohydrate metabolic process | GO:0044723 | 193 | 0.014 | |
| positive regulation of protein catabolic process | GO:0045732 | 75 | 0.014 | |
| metal ion transport | GO:0030001 | 272 | 0.014 | |
| regulation of protein transport | GO:0051223 | 213 | 0.014 | |
| double strand break repair | GO:0006302 | 101 | 0.014 | |
| defense response | GO:0006952 | 315 | 0.014 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.014 | |
| protein autophosphorylation | GO:0046777 | 123 | 0.013 | |
| secretion | GO:0046903 | 254 | 0.013 | |
| regulation of protein kinase activity | GO:0045859 | 289 | 0.013 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.013 | |
| positive regulation of transferase activity | GO:0051347 | 227 | 0.013 | |
| response to hexose | GO:0009746 | 20 | 0.013 | |
| tripartite regional subdivision | GO:0007351 | 2 | 0.013 | |
| axon development | GO:0061564 | 34 | 0.013 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 22 | 0.013 | |
| nuclear envelope reassembly | GO:0031468 | 3 | 0.013 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.013 | |
| response to reactive oxygen species | GO:0000302 | 61 | 0.013 | |
| response to inorganic substance | GO:0010035 | 127 | 0.013 | |
| response to other organism | GO:0051707 | 261 | 0.013 | |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 132 | 0.013 | |
| negative regulation of mapk cascade | GO:0043409 | 56 | 0.013 | |
| regulation of peptide transport | GO:0090087 | 62 | 0.013 | |
| establishment or maintenance of cytoskeleton polarity | GO:0030952 | 3 | 0.013 | |
| cell death in response to oxidative stress | GO:0036473 | 29 | 0.013 | |
| sister chromatid segregation | GO:0000819 | 54 | 0.013 | |
| lipid homeostasis | GO:0055088 | 39 | 0.013 | Fly |
| positive regulation of ras gtpase activity | GO:0032320 | 117 | 0.013 | |
| regulation of phosphatase activity | GO:0010921 | 81 | 0.013 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 43 | 0.013 | |
| axis elongation | GO:0003401 | 4 | 0.013 | |
| maintenance of location | GO:0051235 | 112 | 0.012 | |
| ribonucleotide catabolic process | GO:0009261 | 405 | 0.012 | |
| multi organism behavior | GO:0051705 | 14 | 0.012 | |
| cation transport | GO:0006812 | 331 | 0.012 | |
| regulation of protein ubiquitination | GO:0031396 | 95 | 0.012 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.012 | |
| protein deglutamylation | GO:0035608 | 1 | 0.012 | |
| regulation of cytokinesis | GO:0032465 | 45 | 0.012 | |
| positive regulation of gtp catabolic process | GO:0033126 | 166 | 0.012 | |
| organic hydroxy compound metabolic process | GO:1901615 | 147 | 0.012 | |
| regulation of ras protein signal transduction | GO:0046578 | 155 | 0.012 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.012 | |
| negative regulation of proteolysis | GO:0045861 | 132 | 0.012 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 37 | 0.012 | Human |
| negative regulation of response to external stimulus | GO:0032102 | 83 | 0.012 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.012 | |
| regulation of axon extension | GO:0030516 | 7 | 0.012 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.012 | Human |
| rab protein signal transduction | GO:0032482 | 4 | 0.011 | |
| cellular protein complex assembly | GO:0043623 | 188 | 0.011 | |
| cell junction assembly | GO:0034329 | 67 | 0.011 | |
| respiratory burst | GO:0045730 | 12 | 0.011 | |
| centrosome duplication | GO:0051298 | 28 | 0.011 | |
| anterior posterior axis specification embryo | GO:0008595 | 2 | 0.011 | |
| developmental growth | GO:0048589 | 48 | 0.011 | |
| oocyte differentiation | GO:0009994 | 2 | 0.011 | |
| regulation of protein maturation | GO:1903317 | 150 | 0.011 | |
| negative regulation of metaphase anaphase transition of cell cycle | GO:1902100 | 17 | 0.011 | |
| cytokine production | GO:0001816 | 247 | 0.011 | |
| negative regulation of cell motility | GO:2000146 | 104 | 0.011 | |
| response to transforming growth factor beta | GO:0071559 | 94 | 0.011 | |
| dna repair | GO:0006281 | 198 | 0.011 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 87 | 0.011 | |
| chromatin modification | GO:0016568 | 298 | 0.011 | |
| regulation of cell size | GO:0008361 | 19 | 0.011 | |
| transmembrane transport | GO:0055085 | 399 | 0.011 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.011 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.011 | |
| central nervous system projection neuron axonogenesis | GO:0021952 | 3 | 0.011 | |
| regulation of intracellular protein transport | GO:0033157 | 123 | 0.011 | |
| regulation of gtpase activity | GO:0043087 | 180 | 0.011 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.011 | |
| phosphatidic acid metabolic process | GO:0046473 | 5 | 0.011 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 91 | 0.011 | |
| fatty acid metabolic process | GO:0006631 | 115 | 0.011 | |
| adult locomotory behavior | GO:0008344 | 1 | 0.011 | |
| histone acetylation | GO:0016573 | 93 | 0.011 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 185 | 0.011 | |
| mitotic spindle assembly checkpoint | GO:0007094 | 14 | 0.011 | |
| response to cytokine | GO:0034097 | 232 | 0.011 | |
| signal transduction involved in dna integrity checkpoint | GO:0072401 | 15 | 0.010 | Human |
| immune system development | GO:0002520 | 195 | 0.010 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.010 | |
| epithelium migration | GO:0090132 | 119 | 0.010 | |
| regulation of mitotic metaphase anaphase transition | GO:0030071 | 26 | 0.010 | |
| lymphocyte activation | GO:0046649 | 133 | 0.010 | |
| calcium ion transport | GO:0006816 | 147 | 0.010 | |
| mitotic sister chromatid segregation | GO:0000070 | 53 | 0.010 | |
| activation of protein kinase activity | GO:0032147 | 90 | 0.010 | |
| glycerolipid metabolic process | GO:0046486 | 107 | 0.010 | |
| leukocyte differentiation | GO:0002521 | 98 | 0.010 | |
| metal ion homeostasis | GO:0055065 | 169 | 0.010 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.010 | |
| signal transduction involved in cell cycle checkpoint | GO:0072395 | 16 | 0.010 | Human |
| protein acylation | GO:0043543 | 138 | 0.010 | |
| eye development | GO:0001654 | 42 | 0.010 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.010 | |
| axonogenesis | GO:0007409 | 31 | 0.010 | |
